- Home
- YY vs CNMD Comparison
YY vs CNMD Comparison
Compare YY & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YY
- CNMD
- Stock Information
- Founded
- YY 2005
- CNMD 1970
- Country
- YY Singapore
- CNMD United States
- Employees
- YY N/A
- CNMD N/A
- Industry
- YY EDP Services
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- YY Technology
- CNMD Health Care
- Exchange
- YY Nasdaq
- CNMD Nasdaq
- Market Cap
- YY 1.9B
- CNMD 2.2B
- IPO Year
- YY 2012
- CNMD 1987
- Fundamental
- Price
- YY $42.36
- CNMD $70.35
- Analyst Decision
- YY Hold
- CNMD Buy
- Analyst Count
- YY 3
- CNMD 6
- Target Price
- YY $35.00
- CNMD $82.83
- AVG Volume (30 Days)
- YY 706.9K
- CNMD 391.7K
- Earning Date
- YY 11-26-2024
- CNMD 01-29-2025
- Dividend Yield
- YY 1.93%
- CNMD 1.14%
- EPS Growth
- YY N/A
- CNMD 127.53
- EPS
- YY 3.11
- CNMD 4.22
- Revenue
- YY $2,258,181,000.00
- CNMD $1,288,116,000.00
- Revenue This Year
- YY $0.62
- CNMD $6.69
- Revenue Next Year
- YY $1.84
- CNMD $7.53
- P/E Ratio
- YY $13.17
- CNMD $16.65
- Revenue Growth
- YY N/A
- CNMD 10.23
- 52 Week Low
- YY $27.88
- CNMD $61.05
- 52 Week High
- YY $42.76
- CNMD $113.68
- Technical
- Relative Strength Index (RSI)
- YY 63.90
- CNMD 46.32
- Support Level
- YY $40.30
- CNMD $67.13
- Resistance Level
- YY $41.63
- CNMD $71.39
- Average True Range (ATR)
- YY 1.65
- CNMD 2.67
- MACD
- YY 0.09
- CNMD -0.32
- Stochastic Oscillator
- YY 95.41
- CNMD 35.78
About YY JOYY Inc.
JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.